Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin

Journal of Clinical Pharmacy and Therapeutics

Volumn 38, Issue 1, 2013, Pages 12-15

  Yokoyama, H ^a   Ito, N ^a   Soeda, S ^b   Ozaki, M ^c   Suzuki, Y ^c   Watanabe, M ^c   Kashiwakura, E ^c   Kawada, T ^c   Ikeda, N ^c   Tokuoka, K ^c   Kitagawa, Y ^c   Yamada, Y ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOKAI UNIVERSITY HOSPITAL   (Japan)

^c TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

Author keywords

antiplatelet effect; aspirin; ibuprofen; interaction; mefenamic acid

Indexed keywords

ACETYLSALICYLIC ACID; COLLAGEN; DICLOFENAC; ETODOLAC; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; LOXOPROFEN; MEFENAMIC ACID; MELOXICAM; NAPROXEN; ROFECOXIB;

AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; FEMALE; HUMAN; MALE; NORMAL HUMAN; STEADY STATE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RICH PLASMA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COLLAGEN; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TIME FACTORS;

EID: 84871969086     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2012.01373.x     Document Type: Article

References (22)

1. Selinsky BS, Gupta K, Sharkey CT, Loll PJ,. Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations. Biochemistry, 2001; 40: 5172-5180. (Pubitemid 32373999)
2. Cryer B, Feldman M,. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med, 1998; 104: 413-421. (Pubitemid 28274844)
3. Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001; 345: 1809-1817.
4. MacDonald TM, Wei L,. Is there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?. Basic Clin Pharmacol Toxicol 2006; 98: 275-280.
5. Interview form of Bufferin 81 mg tablets. 2008.
6. Interview form of Brufen tablets. 2008.
7. Hideo N, Yuko M, Yukinori K,. Study of pharmacokinetics following oral administration of loxoprofen sodium (CS-600) in humans. J Clin Ther Med, 1986; 2: 1219-1237.
8. Paul EG, James MD,. Bioavailability of indomethacin tables in men volunteers. Clin Pharm, 1986; 5: 820-824.
9. Yutaka M, Munetetsu T, Akifumi Y, et al. Tolerability and bioavailability of diclofenac after single administration of Voltaren® tablet and suppository in healthy volunteers. Japanese J Inflamm, 1988; 5: 475482.
10. Kinya K, Daisuke F, Teruo K,. Phase 1 study of RAK-591 (etodolac). J Clin Ther Med, 1987; 3: 419-446.
11. Rawashdeh NM, Najib NM, Jalal IM,. Comparative bioavailability of two capsule formulations of mefenamic acid. Int J Clin Pharmacol Ther, 1997; 35: 329-333. (Pubitemid 27354910)
12. Interview form of Mobic tablets. 2009.
13. Sarfaraz K, Niazi S, Mahmood A, Ahmad SI,. Dose dependent pharmacokinetics of naproxen in man. Biopharm Drug Dispos, 1996; 17: 355-361. (Pubitemid 26178153)
14. Interview form of Froben tablets. 2010.
15. Botting RM,. Inhibitors of cyclooxygenases: mechanisms, selectivity and uses. J Physiol Pharmacol, 2006; 57: 113-124. (Pubitemid 46569788)
16. Eugene ML, Abraham S, Ivan M, Nancy O, Carole S, Nilda M,. The correlation between blood levels of ibuprofen and clinical analgesic response. Clin Pharmacol Ther, 1986; 40: 1-7.
17. Schuijt MP, Huntjens-Fleuren HWHA, Metz M, Vollaard EJ,. The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers. Br J Pharmacol, 2009; 157: 931-934.
18. Katja S, Galliard G, Martin F, Walter HR,. Influence of combinations of acetylsalicylic acid, acetaminophen, and diclofenac on platelet aggregation. Eur J Pharmacol, 2008; 595: 65-68.
19. Kelly TP, William JS, Roy CP,. Effect of flurbiprofen and aspirin on platelet aggregation. Clin Pharm, 1991; 10: 935-938.
20. Francis MG, Lisa R, Matthew R, Michelle R, Michael FG, Donald EM, Vernice B,. Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis. J Clin Pharmacol, 2008; 48: 117-122.
21. Joanne VR, Monika KE, Ingrid K, et al. Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers. J Clin Pharmacol, 2004; 44: 777-784.
22. Marte LC, Maria GS, Stefania T, et al. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. J Am Coll Cardiol, 2005; 45: 1295-1301.